Skip to main content
Premium Trial:

Request an Annual Quote

Agilent to Market, Sell ExonHit SpliceArrays Worldwide

NEW YORK, May 31 (GenomeWeb News) - Agilent Technologies will market and sell ExonHit's line of splice variant arrays as commercial products worldwide, the companies said today.   

 

Agilent will now offer nine different ExonHit human and mouse SpliceArrays through its offices globally.

 

ExonHit's SpliceArray technology "also complements [Agilent's existing] portfolio of microarray-based research tools," Fran Dinuzzo, Agilent's vice president and general manager of integrated biology solutions, said in a statement.

 

Agilent originally agreed to distribute ExonHit's arrays last August. The arrays were initially offered only through a service when they were launched by ExonHit in February 2005.

 

Financial details of the new alliance were not discussed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.